The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 560-564

  Furenes, Eline B ^a   Arnesen, Harald ^a   Solheim, Svein ^a   Grøgaard, Haakon K ^a   Hoffmann, Pavel ^a   Seljeflot, Ingebjørg ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myocardial infarction; Metalloproteinase 9; Percutaneous Coronary intervention; Pregnancy associated plasma protein; Stable angina pectoris

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; GELATINASE B; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REDUCTION; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS;

ACUTE DISEASE; ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 70349878577     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.04.001     Document Type: Article

References (23)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51 (2005) 810-824
3. Kelly D., Cockerill G., Ng L.L., Thompson M., Khan S., Samani N.J., et al. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 28 (2007) 711-718
4. Cheng M., Hashmi S., Mao X., and Zeng Q.T. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome. Can J Cardiol 24 (2008) 385-390
5. Hlatky M.A., Ashley E., Quertermous T., Boothroyd D.B., Ridker P., Southwick A., et al. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Am Heart J 154 (2007) 1043-1051
6. Derosa G., D'Angelo A., Ciccarelli L., Piccinni M.N., Pricolo F., Salvadeo S., et al. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 13 (2006) 227-231
7. Tayebjee M.H., Nadar S., Blann A.D., Gareth B.D., Macfadyen R.J., and Lip G.Y. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens 17 (2004) 764-769
8. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes Jr. D.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
9. Cosin-Sales J., Kaski J.C., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 26 (2005) 2093-2098
10. Hoffmann P., Halvorsen S., Stensaeth K.H., Brekke M., Muller C., Anker G.O., et al. Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty. Scand Cardiovasc J 40 (2006) 96-104
11. Solheim S., Grogaard H.K., Hoffmann P., Arnesen H., and Seljeflot I. Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest 18 (2008) 1-8
12. Webb C.S., Bonnema D.D., Ahmed S.H., Leonardi A.H., McClure C.D., Clark L.L., et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 5 114 (2006) 1020-1027
13. Lee S.W., Song K.E., Shin D.S., Ahn S.M., Ha E.S., Kim D.J., et al. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes. Diabetes Res Clin Pract 69 (2005) 175-179
14. Segarra M., Vilardell C., Matsumoto K., Esparza J., Lozano E., Serra-Pages C., et al. Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells. FASEB J 19 (2005) 1875-1877
15. Etoh T., Joffs C., Deschamps A.M., Davis J., Dowdy K., Hendrick J., et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol 281 (2001) H987-H994
16. May A.E., Kalsch T., Massberg S., Herouy Y., Schmidt R., and Gawaz M. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 15 106 (2002) 2111-2117
17. Kai H., Ikeda H., Yasukawa H., Kai M., Seki Y., Kuwahara F., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32 (1998) 368-372
18. Seo D.W., Li H., Guedez L., Wingfield P.T., Diaz T., Salloum R., et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 25 114 (2003) 171-180
19. Johnson J.L., Baker A.H., Oka K., Chan L., Newby A.C., Jackson C.L., et al. Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation 23 113 (2006) 2435-2444
20. Elesber A.A., Lerman A., Denktas A.E., Resch Z.T., Jared B.T., Schwartz R.S., et al. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol 117 (2007) 365-369
21. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., and Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 18 45 (2005) 229-237
22. Lund J., Qin Q.P., Ilva T., Nikus K., Eskola M., Porela P., et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 38 (2006) 221-228
23. Noji Y., Kajinami K., Kawashiri M.A., Todo Y., Horita T., Nohara A., et al. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med 39 (2001) 380-384